ArticleAnti-cancer drugs2018

9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma.

Andrey V Ugolkov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.